-
Something wrong with this record ?
Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression
J. Sirc, Z. Hampejsova, J. Trnovska, P. Kozlik, J. Hrib, R. Hobzova, A. Zajicova, V. Holan, Z. Bosakova,
Language English Country United States
Document type Journal Article
NLK
ProQuest Central
from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2010-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 1997-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01 to 1 year ago
- MeSH
- Cell Line MeSH
- Cyclosporine administration & dosage chemistry MeSH
- Hydrophobic and Hydrophilic Interactions MeSH
- Immunosuppressive Agents administration & dosage chemistry MeSH
- Kinetics MeSH
- Culture Media MeSH
- Humans MeSH
- Nanofibers chemistry MeSH
- Drug Carriers MeSH
- Polyesters chemistry MeSH
- Polyethylene Glycols chemistry MeSH
- Surface Properties MeSH
- Spleen cytology MeSH
- Tissue Culture Techniques MeSH
- Drug Liberation MeSH
- Particle Size MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
PURPOSE: The present study aims to prepare poly(D,L-lactic acid) (PLA) nanofibers loaded by the immunosuppressant cyclosporine A (CsA, 10 wt%). Amphiphilic poly(ethylene glycol)s (PEG) additives were used to modify the hydrophobic drug release kinetics. METHODS: Four types of CsA-loaded PLA nanofibrous carriers varying in the presence and molecular weight (MW) of PEG (6, 20 and 35 kDa) were prepared by needleless electrospinning. The samples were extracted for 144 h in phosphate buffer saline or tissue culture medium. A newly developed and validated LC-MS/MS method was utilized to quantify the amount of released CsA from the carriers. In vitro cell experiments were used to evaluate biological activity. RESULTS: Nanofibers containing 15 wt% of PEG showed improved drug release characteristics; significantly higher release rates were achieved in initial part of experiment (24 h). The highest released doses of CsA were obtained from the nanofibers with PEG of the lowest MW (6 kDa). In vitro experiments on ConA-stimulated spleen cells revealed the biological activity of the released CsA for the whole study period of 144 h and nanofibers containing PEG with the lowest MW exhibited the highest impact (inhibition). CONCLUSIONS: The addition of PEG of a particular MW enables to control CsA release from PLA nanofibrous carriers. The biological activity of CsA-loaded PLA nanofibers with PEG persists even after 144 h of previous extraction. Prepared materials are promising for local immunosuppression in various medical applications.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18025084
- 003
- CZ-PrNML
- 005
- 20180718101911.0
- 007
- ta
- 008
- 180709s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11095-017-2155-x $2 doi
- 035 __
- $a (PubMed)28405914
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sirc, Jakub $u Department of Polymer Networks and Gels, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
- 245 10
- $a Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression / $c J. Sirc, Z. Hampejsova, J. Trnovska, P. Kozlik, J. Hrib, R. Hobzova, A. Zajicova, V. Holan, Z. Bosakova,
- 520 9_
- $a PURPOSE: The present study aims to prepare poly(D,L-lactic acid) (PLA) nanofibers loaded by the immunosuppressant cyclosporine A (CsA, 10 wt%). Amphiphilic poly(ethylene glycol)s (PEG) additives were used to modify the hydrophobic drug release kinetics. METHODS: Four types of CsA-loaded PLA nanofibrous carriers varying in the presence and molecular weight (MW) of PEG (6, 20 and 35 kDa) were prepared by needleless electrospinning. The samples were extracted for 144 h in phosphate buffer saline or tissue culture medium. A newly developed and validated LC-MS/MS method was utilized to quantify the amount of released CsA from the carriers. In vitro cell experiments were used to evaluate biological activity. RESULTS: Nanofibers containing 15 wt% of PEG showed improved drug release characteristics; significantly higher release rates were achieved in initial part of experiment (24 h). The highest released doses of CsA were obtained from the nanofibers with PEG of the lowest MW (6 kDa). In vitro experiments on ConA-stimulated spleen cells revealed the biological activity of the released CsA for the whole study period of 144 h and nanofibers containing PEG with the lowest MW exhibited the highest impact (inhibition). CONCLUSIONS: The addition of PEG of a particular MW enables to control CsA release from PLA nanofibrous carriers. The biological activity of CsA-loaded PLA nanofibers with PEG persists even after 144 h of previous extraction. Prepared materials are promising for local immunosuppression in various medical applications.
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a kultivační média $7 D003470
- 650 _2
- $a cyklosporin $x aplikace a dávkování $x chemie $7 D016572
- 650 _2
- $a nosiče léků $7 D004337
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a imunosupresiva $x aplikace a dávkování $x chemie $7 D007166
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a nanovlákna $x chemie $7 D057139
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a polyestery $x chemie $7 D011091
- 650 _2
- $a polyethylenglykoly $x chemie $7 D011092
- 650 _2
- $a slezina $x cytologie $7 D013154
- 650 _2
- $a povrchové vlastnosti $7 D013499
- 650 _2
- $a techniky tkáňových kultur $7 D046509
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hampejsova, Zuzana $u Department of Analytical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Trnovska, Jana $u Department of Analytical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Kozlik, Petr $u Department of Analytical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Hrib, Jakub $u Department of Polymer Networks and Gels, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
- 700 1_
- $a Hobzova, Radka $u Department of Polymer Networks and Gels, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
- 700 1_
- $a Zajicova, Alena $u Department of Transplantation Immunology, Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.
- 700 1_
- $a Holan, Vladimir $u Department of Transplantation Immunology, Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.
- 700 1_
- $a Bosakova, Zuzana $u Department of Analytical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic. bosakova@natur.cuni.cz.
- 773 0_
- $w MED00003779 $t Pharmaceutical research $x 1573-904X $g Roč. 34, č. 7 (2017), s. 1391-1401
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28405914 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180718102212 $b ABA008
- 999 __
- $a ok $b bmc $g 1317215 $s 1022005
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 34 $c 7 $d 1391-1401 $e 20170412 $i 1573-904X $m Pharmaceutical research $n Pharm Res $x MED00003779
- LZP __
- $a Pubmed-20180709